Texas runs out of antibody treatment effective against omicron

Five regional infusion centers in Texas have run out of sotrovimab, the only COVID-19 monoclonal antibody treatment that appears to be effective against the omicron variant, the Department of Health and Human Services said Dec. 27.

Advertisement

The agency said centers in Austin, El Paso, Fort Worth, San Antonio and The Woodlands have exhausted their supplies of the treatment, citing national scarcity. The agency added that affected centers will not be able to offer sotrovimab until the government ships more supplies in January. 

Antibodies as prescribed by providers for patients diagnosed with non-omicron cases will continue to be administered.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.